The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Delafloxacin     1-(6-amino-3,5-difluoro- pyridin-2-yl)-8...

Synonyms: QCR-52, AC1LAFLM, ABT-492, S1553_Selleck, ABT492, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of WQ-3034

 

High impact information on WQ-3034

References

  1. In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Gunderson, S.M., Hayes, R.A., Quinn, J.P., Danziger, L.H. Antimicrob. Agents Chemother. (2004) [Pubmed]
  2. In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis. Goldstein, E.J., Citron, D.M., Merriam, C.V., Warren, Y.A., Tyrrell, K.L., Fernandez, H.T. Antimicrob. Agents Chemother. (2003) [Pubmed]
  3. In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone. Nilius, A.M., Shen, L.L., Hensey-Rudloff, D., Almer, L.S., Beyer, J.M., Balli, D.J., Cai, Y., Flamm, R.K. Antimicrob. Agents Chemother. (2003) [Pubmed]
  4. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tomioka, H., Sato, K., Kajitani, H., Akaki, T., Shishido, S. Antimicrob. Agents Chemother. (2000) [Pubmed]
  5. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492. Harnett, S.J., Fraise, A.P., Andrews, J.M., Jevons, G., Brenwald, N.P., Wise, R. J. Antimicrob. Chemother. (2004) [Pubmed]
  6. Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodology. Andrews, J.M., Ashby, J.P., Jevons, G., Wise, R. J. Antimicrob. Chemother. (2003) [Pubmed]
 
WikiGenes - Universities